RBC Capital downgrades Chemours stock rating on TiO2 weakness

Markets Investing.com By Investing.com 13 Oct 2026 07:16 1 min read
RBC Capital downgrades Chemours stock rating on TiO2 weakness

Covered in this story

What has happened since

  • RBC Bearings is down 0.6% since this was published.
  • Chemours is down 2.3% since this was published.

Price move measured from the close nearest publication to the latest quote.

Tracked from this story

RBC Capital Markets’s $14 target on $CC is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.

RBC Capital Markets’s track record →

Call it yourself

No member calls on $RBC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on RBC Bearings →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.